FDA.reportPublic FDA data

Application 040766

Type
ANDA
Sponsor
IPCA LABS LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001HYDROXYCHLOROQUINE SULFATEHYDROXYCHLOROQUINE SULFATETABLET;ORAL200MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
10544-578Hydroxychloroquine SulfateHydroxychloroquine SulfateBlenheim Pharmacal, Inc.ANDACurrent
21695-486Hydroxychloroquine SulfateHydroxychloroquine SulfateRebel Distributors CorpANDACurrent
33261-933Hydroxychloroquine SulfateHydroxychloroquine SulfateAidarex Pharmaceuticals LLCANDACurrent
43353-972Hydroxychloroquine SulfateHydroxychloroquine SulfateAphena Pharma Solutions - Tennessee, LLCANDACurrent
50090-0681Hydroxychloroquine SulfateHydroxychloroquine SulfateA-S Medication SolutionsANDACurrent
51660-296Hydroxychloroquine SulfateHydroxychloroquine SulfateOhm Laboratories Inc.ANDACurrent
53808-1112Hydroxychloroquine SulfateHydroxychloroquine SulfateDOH CENTRAL PHARMACYANDACurrent
63304-296Hydroxychloroquine SulfateHydroxychloroquine SulfateSun Pharmaceutical Industries, Inc.ANDACurrent
66336-555Hydroxychloroquine SulfateHydroxychloroquine SulfateDispensing Solutions, Inc.ANDACurrent
76385-144Hydroxychloroquine SulfateHydroxychloroquine SulfateBayshore Pharmaceuticals LLCANDACurrent
76385-144Hydroxychloroquine SulfateHydroxychloroquine SulfateBayshore Pharmaceuticals LLCANDACurrent
76385-144Hydroxychloroquine SulfateHydroxychloroquine SulfateBayshore Pharmaceuticals LLCANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
62495SUPPL2020-04-08
62494SUPPL2020-04-08